Scientists may have found a way to target specific receptors in the brain so that drugs may better treat the cognitive and motor problems related to schizophrenia and Alzheimer's disease. Drugmakers have long known that certain compounds activate two specific receptors in the brain--called CNS receptors--that help ease motor and cognitive symptoms. But when used in the medications, the compounds activated all the brain's CNS receptors, resulting in unacceptable side effects. But now scientists...
Read moreTreatment in childhood with epilepsy medications may be linked to the development of schizophrenia later in life, some researchers say. Scientists... Read more »
A mother writes that her son, who has been diagnosed with schizophrenia, stops taking his Risperdal when he is feeling better. She then has... Read more »
Policies that place restrictions on schizophrenia medications cause some patients to stop taking the drugs, new research suggests. Scientists looked... Read more »
Scientists have discovered a gene that may control the way some people who suffer from schizophrenia and bipolar disorder respond to medications, and... Read more »
This is a study to compare the safety and cognitive effects of a new drug (GSK239512) to a placebo in people who have schizophrenia. This national... Read more »